Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enphase Energy Inc (ENPH) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance

Enphase Energy IncTrade
NeoGenomics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Enphase Energy Inc vs NeoGenomics Inc. Common Stock — how do they compare? Enphase Energy Inc trades at $28.72 (market cap $4.23B), while NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B). The key difference: Enphase Energy Inc is the larger of the two by market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Enphase Energy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and NeoGenomics Inc. Common Stock for 0 Days on average.

ENPHNEO
Market Cap
$4.23B$2.17B
Volume
4,755,8971,615,943
Sector
EnergyHealth
52-Week High
$72.33$19.91
52-Week Low
$26.12$7.19
Typical Hold Time
72 Days0 Days
Enterprise Value
$3.88B$2.47B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enphase Energy Inc

Enphase Energy (ENPH) trades at $32.03, up 1.71% on the day, but remains in a technical downtrend with a bearish moving average signal. The stock faces pressure from recent earnings misses in Q1 and Q2 2026, though it beat expectations in Q4 2025. Revenue declined from $2.3B in 2023 to $1.47B in 2025, but net income margin improved to 11.68%. Recent news highlights product approvals and expansion into AI data center power solutions, providing potential growth catalysts amid a challenging solar sector environment.

The outlook is mixed; analyst consensus is a Buy with a $42.68 price target, implying significant upside, but high borrowing costs and solar industry headwinds pose risks. The stock's current valuation at a P/E of 31.71 may limit near-term gains if earnings growth stalls. Investors should weigh the company's innovation in smart energy solutions against macroeconomic pressures and competitive dynamics in the renewable energy market.

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENPH
68% Buy32% Sell
Avg holding period · 72 Days
NEO
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Enphase Energy Inc

Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.

Read more on ENPH →

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →